发明名称 Dispositivo de iontoforesis ocular que disminuye las irritaciones
摘要 An ocular iontophoresis device for delivering a medication, comprises a medication reservoir suitable for being positioned on an eye; medication(s) in solution in the reservoir; an active electrode disposed in the reservoir; and a passive electrode. The medication is dissolved in non-saline water. It includes an active principle associated with an additive, e.g. a dendrimer, a polymer, a nanoparticle, a microsphere, a liposome or an emulsion. An ocular iontophoresis device (1) for delivering a medication, comprises a medication reservoir (20) suitable for being positioned on an eye; medication(s) (30) in solution in the reservoir; an active electrode (10) disposed in the reservoir; and a passive electrode (40). The medication is dissolved in non-saline water. The solution has a pH of 6.5-8.5. The medication includes an active principle associated with an additive, e.g. a dendrimer, a polymer, a nanoparticle, a microsphere, a liposome, or an emulsion. It has a pKa of 5.5-9.5, and an ionic form of valency of >=1. An independent claim is also included for a method of treatment by ocular iontophoresis, comprising positioning the above iontophoresis device on the eye to deliver medication; and implementing ocular iontophoresis by using the iontophoresis device.
申请公布号 ES2569329(T3) 申请公布日期 2016.05.10
申请号 ES20050763701T 申请日期 2005.04.29
申请人 EYEGATE PHARMA SAS 发明人 ROY, Pierre
分类号 A61K33/00;A61F2/00;A61F9/00;A61N1/30 主分类号 A61K33/00
代理机构 代理人
主权项
地址